based on pharmacodynamic and pharmacokinetic studies in 42 patients with paroxysmal and extrasystolic abnormalities of the rhythm it was established that disopyramide phosphate ( ritmilen ) is an effective antiarrhythmic agent for atrial fibrillation paroxysms .
C0700534
disopyramide phosphate
C0003195
antiarrhythmic agent